These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 33751617)

  • 61. Assessment of eligibility for thrombolysis in acute ischaemic stroke patients in Morocco.
    Acherqui M; Khattab H; Habtany Y; Amzil R; Bellakhdar S; Otmani HE; Moutawakil BE; Rafai MA
    Pan Afr Med J; 2020; 36():351. PubMed ID: 33224417
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke.
    Clark WM; Wissman S; Albers GW; Jhamandas JH; Madden KP; Hamilton S
    JAMA; 1999 Dec; 282(21):2019-26. PubMed ID: 10591384
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Cluster-Randomized Trial of Thrombolysis Implementation Support in Metropolitan and Regional Australian Stroke Centers: Lessons for Individual and Systems Behavior Change.
    Levi CR; Attia JA; D'Este C; Ryan AE; Henskens F; Kerr E; Parsons MW; Sanson-Fisher RW; Bladin CF; Lindley RI; Middleton S; Paul CL; ;
    J Am Heart Assoc; 2020 Feb; 9(3):e012732. PubMed ID: 31973599
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Expanded Indication for Recombinant Tissue Plasminogen Activator from 3 to 4.5 h after Onset of Stroke in Japan.
    Miyamoto Y; Aso S; Iwagami M; Morita K; Fushimi K; Hamasaki Y; Nangaku M; Doi K; Yasunaga H
    J Stroke Cerebrovasc Dis; 2020 Dec; 29(12):105341. PubMed ID: 33039772
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Ischaemic stroke: decide rapidly.
    Prescrire Int; 2015 Sep; 24(163):221. PubMed ID: 26417638
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Rescue localized intra-arterial thrombolysis for hyperacute MCA ischemic stroke patients after early non-responsive intravenous tissue plasminogen activator therapy.
    Kim DJ; Kim DI; Kim SH; Lee KY; Heo JH; Han SW
    Neuroradiology; 2005 Aug; 47(8):616-21. PubMed ID: 15983773
    [TBL] [Abstract][Full Text] [Related]  

  • 67. A Decade of Improvement in Door-to-Needle Time Among Acute Ischemic Stroke Patients, 2008 to 2017.
    Tong X; Wiltz JL; George MG; Odom EC; Coleman King SM; Chang T; Yin X; ; Merritt RK
    Circ Cardiovasc Qual Outcomes; 2018 Dec; 11(12):e004981. PubMed ID: 30557047
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Reducing Door-to-Needle Times for Ischaemic Stroke to a Median of 30 Minutes at a Community Hospital.
    Kamal N; Shand E; Swanson R; Hill MD; Jeerakathil T; Imoukhuede O; Heinrichs I; Bakker J; Stoyberg C; Fowler L; Duckett S; Holsworth S; Mann B; Valaire S; Bestard J
    Can J Neurol Sci; 2019 Jan; 46(1):51-56. PubMed ID: 30516454
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Thrombolysis in acute ischemic stroke with intravenous recombinant tissue-type plasminogen activator].
    May Z; Kakuk I; Ováry C; Ricsóy G; Skopál J; Szegedi N; Varga D; Nagy Z
    Orv Hetil; 2002 Nov; 143(44):2479-84. PubMed ID: 12674802
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Direct access to a hospital offering intravenous thrombolysis therapy improves functional outcome of acute ischemic stroke patients.
    Kim DH; Cha JK; Park HS; Choi JH; Kang MJ; Huh JT
    J Clin Neurosci; 2014 Aug; 21(8):1428-32. PubMed ID: 24980628
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Comparison of tissue plasminogen activator administration management between Telestroke Network hospitals and academic stroke centers: the Telemedical Pilot Project for Integrative Stroke Care in Bavaria/Germany.
    Audebert HJ; Kukla C; Vatankhah B; Gotzler B; Schenkel J; Hofer S; Fürst A; Haberl RL
    Stroke; 2006 Jul; 37(7):1822-7. PubMed ID: 16763192
    [TBL] [Abstract][Full Text] [Related]  

  • 72. A case-controlled comparison of thrombolysis outcomes between wake-up and known time of onset ischemic stroke patients.
    Manawadu D; Bodla S; Jarosz J; Keep J; Kalra L
    Stroke; 2013 Aug; 44(8):2226-31. PubMed ID: 23723307
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Telemedicine in Prehospital Stroke Evaluation and Thrombolysis: Taking Stroke Treatment to the Doorstep.
    Itrat A; Taqui A; Cerejo R; Briggs F; Cho SM; Organek N; Reimer AP; Winners S; Rasmussen P; Hussain MS; Uchino K;
    JAMA Neurol; 2016 Feb; 73(2):162-8. PubMed ID: 26641366
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Mobilization after thrombolysis (rtPA) within 24 hours of acute stroke: what factors influence inclusion of patients in A Very Early Rehabilitation Trial (AVERT)?
    Muhl L; Kulin J; Dagonnier M; Churilov L; Dewey H; Lindén T; Bernhardt J
    BMC Neurol; 2014 Aug; 14():163. PubMed ID: 25159047
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Emergency medicine residents in the implementation of thrombolysis for acute ischemic stroke.
    Hälinen M; Mattila K; Janhunen H
    Duodecim; 2016; 132(24):2342-48. PubMed ID: 29199794
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Off-label thrombolysis versus full adherence to the current European Alteplase license: impact on early clinical outcomes after acute ischemic stroke.
    Cappellari M; Moretto G; Micheletti N; Donato F; Tomelleri G; Gulli G; Carletti M; Squintani GM; Zanoni T; Ottaviani S; Romito S; Tommasi G; Musso AM; Deotto L; Gambina G; Zimatore DS; Bovi P
    J Thromb Thrombolysis; 2014 May; 37(4):549-56. PubMed ID: 23943338
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Intraarterial Thrombolysis as Rescue Therapy for Large Vessel Occlusions.
    Zaidi SF; Castonguay AC; Jumaa MA; Malisch TW; Linfante I; Marden FA; Abraham MG; Chebl AB; Novakovic R; Taqi MA; Nogueira RG; Martin CO; Holloway WE; Mueller-Kronast N; English JD; Dabus G; Bozorgchami H; Xavier A; Rai AT; Froehler MT; Badruddin A; Nguyen TN; Yoo AJ; Shaltoni H; Janardhan V; Chen PR; Britz GW; Kaushal R; Nanda A; Gupta R; Zaidat OO
    Stroke; 2019 Apr; 50(4):1003-1006. PubMed ID: 30791829
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Acute stroke management in the elderly.
    Zeevi N; Chhabra J; Silverman IE; Lee NS; McCullough LD
    Cerebrovasc Dis; 2007; 23(4):304-8. PubMed ID: 17199089
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Intravenous Thrombolysis After Idarucizumab Application in Acute Stroke Patients-A Potentially Increased Sensitivity of Thrombi to Lysis?
    Pretnar Oblak J; Sabovic M; Frol S
    J Stroke Cerebrovasc Dis; 2019 Mar; 28(3):768-773. PubMed ID: 30527792
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Phased changes in strategies can reduce delay of intravenous thrombolysis administration to 15 min.
    Itabashi R; Shigehatake Y; Yazawa Y; Endo K; Saito T; Fukuma K; Furui E; Mori E
    J Neurol Sci; 2019 Aug; 403():59-64. PubMed ID: 31226551
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.